SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001326110-24-000069
Filing Date
2024-06-12
Accepted
2024-06-12 16:36:10
Documents
13
Period of Report
2024-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ibrx-20240611.htm   iXBRL 8-K 53697
  Complete submission text file 0001326110-24-000069.txt   179687

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ibrx-20240611.xsd EX-101.SCH 1985
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ibrx-20240611_lab.xml EX-101.LAB 21876
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ibrx-20240611_pre.xml EX-101.PRE 12585
16 EXTRACTED XBRL INSTANCE DOCUMENT ibrx-20240611_htm.xml XML 2718
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Filer) CIK: 0001326110 (see all company filings)

IRS No.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37507 | Film No.: 241038888
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)